CEFAZOLIN

N/A

Manufactured by Apotex Corp.

16,465 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CEFAZOLIN

CEFAZOLIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Apotex Corp.. The most commonly reported adverse reactions for CEFAZOLIN include DRUG INEFFECTIVE, HYPOTENSION, ANAPHYLACTIC REACTION, RASH, RENAL FAILURE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFAZOLIN.

Top Adverse Reactions

DRUG INEFFECTIVE586 reports
HYPOTENSION542 reports
ANAPHYLACTIC REACTION470 reports
RASH454 reports
RENAL FAILURE437 reports
PAIN386 reports
PYREXIA370 reports
ACUTE KIDNEY INJURY360 reports
ANAPHYLACTIC SHOCK325 reports
OFF LABEL USE310 reports
DRUG HYPERSENSITIVITY303 reports
ANXIETY297 reports
NAUSEA279 reports
URTICARIA273 reports
DYSPNOEA254 reports
INJURY240 reports
DRUG INTERACTION234 reports
UNEVALUABLE EVENT230 reports
CARDIAC ARREST229 reports
VOMITING221 reports
CHRONIC KIDNEY DISEASE216 reports
ERYTHEMA216 reports
EMOTIONAL DISTRESS199 reports
RENAL IMPAIRMENT196 reports
RENAL INJURY195 reports
TACHYCARDIA192 reports
ANAEMIA188 reports
PRURITUS182 reports
DEATH181 reports
DIARRHOEA181 reports
FEAR177 reports
PRODUCT USE IN UNAPPROVED INDICATION169 reports
PNEUMONIA163 reports
CONDITION AGGRAVATED161 reports
ANHEDONIA160 reports
CELLULITIS160 reports
INFECTION157 reports
SEPSIS153 reports
RESPIRATORY FAILURE144 reports
THROMBOCYTOPENIA143 reports
CLOSTRIDIUM DIFFICILE COLITIS141 reports
STRESS133 reports
ABDOMINAL PAIN131 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS131 reports
FOETAL EXPOSURE DURING PREGNANCY131 reports
MULTI ORGAN FAILURE130 reports
HYPERTENSION129 reports
DEPRESSION127 reports
ARTHRALGIA124 reports
BLOOD PRESSURE DECREASED124 reports
FALL123 reports
FATIGUE123 reports
BRADYCARDIA122 reports
BLOOD CREATININE INCREASED120 reports
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS119 reports
ABDOMINAL DISCOMFORT118 reports
MATERNAL EXPOSURE DURING PREGNANCY115 reports
HYPOXIA114 reports
SEPTIC SHOCK112 reports
HYPERSENSITIVITY109 reports
RENAL FAILURE ACUTE109 reports
PANCYTOPENIA107 reports
EXPOSURE DURING PREGNANCY106 reports
OXYGEN SATURATION DECREASED106 reports
PREMATURE BABY106 reports
ASTHENIA105 reports
BRONCHOSPASM103 reports
HEADACHE103 reports
BACK PAIN101 reports
ANGIOEDEMA100 reports
RHEUMATOID ARTHRITIS99 reports
ALANINE AMINOTRANSFERASE INCREASED98 reports
CONFUSIONAL STATE97 reports
METABOLIC ACIDOSIS97 reports
ATRIAL FIBRILLATION96 reports
DRUG INDUCED LIVER INJURY96 reports
DIZZINESS95 reports
CHILLS93 reports
DEEP VEIN THROMBOSIS91 reports
NEUTROPENIA91 reports
STAPHYLOCOCCAL INFECTION90 reports
END STAGE RENAL DISEASE88 reports
CHEST PAIN87 reports
MALAISE86 reports
URINARY TRACT INFECTION86 reports
FUNGAL INFECTION85 reports
PLEURAL EFFUSION85 reports
COAGULOPATHY84 reports
OEDEMA PERIPHERAL84 reports
PULMONARY EMBOLISM84 reports
BACTERIAL INFECTION83 reports
HAEMOGLOBIN DECREASED83 reports
RESPIRATORY DISTRESS81 reports
CLOSTRIDIUM TEST POSITIVE80 reports
LYMPHOPENIA80 reports
PAIN IN EXTREMITY80 reports
HYPOKALAEMIA79 reports
COUGH78 reports
CARDIO RESPIRATORY ARREST77 reports
RASH MACULO PAPULAR77 reports

Report Outcomes

Out of 8,790 classified reports for CEFAZOLIN:

Serious 92.8%Non-Serious 7.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male4,094 (50.6%)
Female3,959 (49.0%)
Unknown34 (0.4%)

Reports by Age

Age 65172 reports
Age 70171 reports
Age 52168 reports
Age 68163 reports
Age 66161 reports
Age 74148 reports
Age 69142 reports
Age 67140 reports
Age 55137 reports
Age 61137 reports
Age 50136 reports
Age 53136 reports
Age 71135 reports
Age 58133 reports
Age 64131 reports
Age 77131 reports
Age 44127 reports
Age 59126 reports
Age 72125 reports
Age 63124 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CEFAZOLIN?

This profile reflects 16,465 FDA FAERS reports that mention CEFAZOLIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CEFAZOLIN?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HYPOTENSION, ANAPHYLACTIC REACTION, RASH, RENAL FAILURE, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CEFAZOLIN?

Labeling and FAERS entries often list Apotex Corp. in connection with CEFAZOLIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.